Ulcerative colitis: Induction Therapy effective with Tofacitinib

被引：0
|
作者：
Kessing, Richard
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2019年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [31] Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis
    Berinstein, Jeffrey A.
    Steiner, Calen A.
    Regal, Randolph E.
    Allen, John, I
    Kinnucan, Jami A. R.
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie B.
    Higgins, Peter D. R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 988 - +
  • [32] Risankizumab induction therapy in ulcerative colitis
    不详
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1076 - 1076
  • [33] Upadacitinib is safe and effective in Ulcerative Colitis patients with prior exposure to Tofacitinib
    Gilmore, R.
    Fernandes, R.
    Hartley, I.
    Arzivian, A.
    Leong, R.
    Andrew, B.
    Vasudevan, A.
    Greeve, T.
    Moore, G.
    Kim, S.
    Lightowler, D.
    Singh, A.
    Mahy, G.
    Mithanthaya, A.
    Venugpal, K.
    Han, S.
    Bryant, R.
    West, J.
    Segal, J.
    Christensen, B.
    Ding, N. J.
    An, Y. K.
    Begun, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1904 - I1904
  • [34] EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
    Berinstein, Jeffrey
    Steiner, Calen
    Regal, Randolph
    Allen, John
    Kinnucan, Jami
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie
    Higgins, Peter
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S22 - S23
  • [35] EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
    Berinstein, Jeffrey
    Steiner, Calen
    Regal, Randolph
    Allen, John
    Kinnucan, Jami
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie
    Higgins, Peter
    GASTROENTEROLOGY, 2019, 156 (03) : S32 - S33
  • [36] Induction and maintenance therapy for ulcerative colitis—vedolizumab more effective than placebo
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 (10) : 564 - 564
  • [37] Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Hart, Ailsa
    Alharbi, Othman R.
    Salese, Leonardo
    Lawendy, Nervin
    Mundayat, Rajiv
    Su, Chinyu
    Reinisch, Walter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S323
  • [38] Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
    Gary R. Lichtenstein
    Benjamin L. Cohen
    Leonardo Salese
    Irene Modesto
    Wenjin Wang
    Gary Chan
    Haytham Mohamed Ahmed
    Chinyu Su
    Laurent Peyrin-Biroulet
    Digestive Diseases and Sciences, 2023, 68 : 2624 - 2634
  • [39] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, Paschalis
    Katsoula, Anastasia
    Giouleme, Olga
    Sarigianni, Maria
    Liakos, Aris
    Athanasiadou, Eleni
    Bekiari, Eleni
    Tsapas, Apostolos
    ANNALS OF GASTROENTEROLOGY, 2018, 31 (05): : 572 - 582
  • [40] Tofacitinib Has Induction Efficacy in Moderately to Severely Active Ulcerative Colitis, Regardless of Prior TNF Inhibitor Therapy
    Sands, Bruce
    D'Haens, Geert
    Sandborn, William J.
    Hibi, Toshifumi
    Su, Chinyu
    Niezychowski, Wojciech
    Ghosh, Subrata
    Zhang, Haiying
    Yu, Dahong
    Woodworth, Deborah
    Healey, Paul
    Marren, Amy
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S261 - S261
12345